.@GladstoneInst's Melanie Ott talks about finding #COVID19 host factors with #CRISPR, and how a new treatment could be different from other antivirals: https://t.co/PUHsii95qb 
Related News
IGI in the Press
Twitter@igisci
Congrats @__Ka1!
Join Kai on a visit to IGI, where she met Jennifer Doudna and learned how to edit DNA with #CRISPR. Check it out in 360° or #VR: https://t.co/7Xhs91yMW3Kai 👩🏽💻 @__Ka1It's been beyond inspiring reading everyone's stories in the @Forbes Next 1000! 😍
You can check out my story, below.
I'm glad to be in such amazing company. 💜
📰 Check out the full list.⬇️
https://t.co/Ln334kodVA https://t.co/0p0jCwtCsZ
What's the latest news on #CRISPR clinical trials? We've got you covered with a comprehensive (and readable!) overview: https://t.co/DmJxIC1yCC 
Hear from Cassandra Trimnell (@sicklecell101) and other panelists discuss why it's important for stakeholders to include #sicklecelldisease patients in the decision-making process: https://t.co/oiSbifeD40 #sicklecellawareness 
Register for free to hear Jennifer Dounda speak about #RareDiseases at 12:25 PT today! ⬇️ Francis S. Collins @NIHDirectorToday #NIH observes #RareDiseaseDay. Join the virtual event to hear about the latest research and resources for #RareDiseases. I’ll give opening remarks around 10:45am ET: https://t.co/WwJgSBrdFt #RDDNIH @NIH @ncats_nih_gov @ORDR @NIHClinicalCntr @genome_gov @theNCI @NINDSnews